Literature DB >> 6460782

Evidence for an influence of the ovary on circulating dehydroepiandrosterone sulfate levels.

D C Cumming, R W Rebar, B R Hopper, S S Yen.   

Abstract

Circulating dehydroepiandrosterone sulfate (DS) declines in old age, falling to almost undetectable levels after the seventh decade. Since an accelerated decrease occurs after the menopause, we sought to determine whether ovarian factors may influence adrenal DS secretion independent of chronological age. DS, cortisol, and estradiol levels were compared in subjects grouped according to age, ovarian function, and estrogen replacement. Our data show that premature ovarian failure and ovariectomy in young as well as in postmenopausal subjects precipitate an earlier decline in DS levels. There were no accompanying changes in cortisol levels and no correlations among levels of DS, cortisol, and estradiol. Long term estrogen replacement (over 10 yr) in postmenopausal women over age 65 had no beneficial effect on the age-related DS decline. We suggest that ovarian factors separate from estrogen-mediated effects significantly influence the reduction of DS levels independent of age.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6460782     DOI: 10.1210/jcem-54-5-1069

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.

Authors:  M Stomati; B Hartmann; A Spinetti; D Mailand; S Rubino; A Albrecht; J Huber; F Petraglia; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1996-09       Impact factor: 4.256

2.  Circulating dehydroepiandrosterone sulfate levels in women who underwent bilateral salpingo-oophorectomy during the menopausal transition.

Authors:  Bill L Lasley; Sybil L Crawford; Gail A Laughlin; Nanette Santoro; Daniel S McConnell; Carolyn Crandall; Gail A Greendale; Alex J Polotsky; Marike Vuga
Journal:  Menopause       Date:  2011-05       Impact factor: 2.953

3.  Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.

Authors:  J Slowinska-Srzednicka; S Zgliczynski; W Jeske; U Stopinska-Gluszak; M Srzednicki; A Brzezinska; W Zgliczynski; Z Sadowski
Journal:  J Endocrinol Invest       Date:  1992 Jul-Aug       Impact factor: 4.256

Review 4.  Normal and Premature Adrenarche.

Authors:  Robert L Rosenfield
Journal:  Endocr Rev       Date:  2021-11-16       Impact factor: 19.871

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.